CIK 0001768224 · Accelerated filer<br>Smaller reporting company
Arcturus Therapeutics Holdings Inc.
Sign in to watch- Ticker
- ARCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 8589002660
- Business address
- 10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-15 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −12,000 | $20.76 | $249K | 435,334 |
| 2024-06-12 | SASSINE ANDY Chief Financial Officer | Sale | −50,000 | $32.03 | $1.6M | 220,526 |
| 2024-06-05 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −114 | $45.00 | $5K | 447,334 |
| 2024-06-03 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −26,000 | $40.01 | $1.0M | 447,448 |
| 2024-03-25 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −17,435 | $35.02 | $611K | 473,448 |
| 2024-03-19 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −8,565 | $35.01 | $300K | 490,883 |
| 2023-11-01 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −5,000 | $18.72 | $94K | 499,448 |
| 2023-10-02 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −5,000 | $25.61 | $128K | 504,448 |
| 2023-09-01 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −5,000 | $31.45 | $157K | 509,448 |
| 2023-08-01 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −5,000 | $34.91 | $175K | 514,448 |
| 2023-07-14 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −25,000 | $35.01 | $875K | 519,448 |
| 2023-07-14 | Kummerfeld Keith C See Remarks | Sale | −6,968 | $35.00 | $244K | 950 |
| 2023-07-03 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −5,000 | $28.75 | $144K | 544,448 |
| 2023-06-01 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −5,000 | $27.16 | $136K | 549,448 |
| 2023-05-11 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −7,925 | $30.24 | $240K | 554,448 |
| 2023-05-10 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −17,075 | $30.00 | $512K | 562,373 |
| 2023-05-01 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −5,000 | $25.93 | $130K | 579,448 |
| 2023-04-18 | Kummerfeld Keith C See Remarks | Sale | −6,968 | $28.18 | $196K | 950 |
| 2023-04-03 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −5,000 | $25.38 | $127K | 584,448 |
| 2023-03-06 | Chivukula Pad Chief Scientific Officer & COO | Sale | −5,000 | $16.07 | $80K | 589,448 |
Page 1 of 2 · 39 trades